Active Pharmaceutical Ingredients (APIs)

  • Sorafenib Tosylate*

    • API Product   :   

      Sorafenib Tosylate*

    • CEP   :   

      -

    • WCC   :   

      ?

    • Therapeutic Use    :   

      Antineoplastics

    • Originator   :   

      Bayer and Onyx Pharmaceuticals

    • CAS No.    :   

      284461-73-0

    • Trade Name.   :   

      NEXAVAR

    • Molecular Weight   :   

      464.825 g/mol

    • Molecular Formula   :   

      C21H16ClF3N4O3

    Application

    Sorafenib is a cancer medication that interferes with the growth and spread of cancer cells in the body. Sorafenib is used to treat liver cancer, thyroid cancer, or a type of kidney cancer called advanced renal cell carcinoma

    General Description

    Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar),[1] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.